Cervical Cancer
Data from Wuhan University advance knowledge in cervical cancer
Published in Women's Health Weekly, December 2nd, 2010
2010 DEC 2 -- New research, 'Effect of ex vivo-expanded 'd-T cells combined with galectin-1 antibody on the growth of human cervical cancer xenografts in SCID mice,' is the subject of a report. "To investigate the antitumor activity of ex vivo-expanded 'd-T cells derived from tumor-infiltrating lymphocytes('dTILs) from cervical cancer patients when combined with galectin-1 antibody and studied both in vitro and in vivo. The presence of 'dTILs in cervical cancer specimens was detected by immunohistochemistry and 'dTILs were expanded using the solid-phase antibody method," scientists writing in the journal Clinical and Investigative Medicine Medecine Clinique Et...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cervical Cancer
Data from D.C. Taylor and colleagues advance knowledge in cervical cancer - Ovarian Cancer
Data from R. Rouzier and colleagues advance knowledge in ovarian cancer - Breast Cancer
Data from University of Adelaide provide new insights into breast cancer - Breast Cancer
Data on breast cancer described by researchers at University of New Mexico - Breast Cancer
Data on breast cancer detailed by P. De and co-authors - Cervical Cancer
Data on cervical cancer published by A. Zucchetto and colleagues - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
